CN102429862A - 一种聚维酮碘眼用缓释滴眼液 - Google Patents
一种聚维酮碘眼用缓释滴眼液 Download PDFInfo
- Publication number
- CN102429862A CN102429862A CN2011103865546A CN201110386554A CN102429862A CN 102429862 A CN102429862 A CN 102429862A CN 2011103865546 A CN2011103865546 A CN 2011103865546A CN 201110386554 A CN201110386554 A CN 201110386554A CN 102429862 A CN102429862 A CN 102429862A
- Authority
- CN
- China
- Prior art keywords
- povidone iodine
- eye drop
- microsphere
- agent
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
- A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
- A61K31/79—Polymers of vinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
处方号 | 约30%溶蚀时间(hr) | 约80%溶蚀时间(hr) | 完全溶蚀时间(hr) |
1 | 0.5 | 4~5 | 8 |
2 | 1 | 6~7 | 12 |
3 | 2 | 8~10 | 12~16 |
4 | 2 | 10~12 | 20~22 |
5 | 3 | 15~20 | 24~30 |
6 | 4 | >24 | >36 |
Claims (9)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011103865546A CN102429862B (zh) | 2011-11-29 | 2011-11-29 | 一种聚维酮碘眼用缓释滴眼液 |
PCT/CN2012/085456 WO2013078998A1 (en) | 2011-11-29 | 2012-11-28 | Novel slow-releasing ophthalmic compositions comprising povidone iodine |
US14/361,242 US9308173B2 (en) | 2011-11-29 | 2012-11-28 | Slow-releasing ophthalmic compositions comprising povidone iodine |
EP12852821.3A EP2785328B1 (en) | 2011-11-29 | 2012-11-28 | Novel slow-releasing ophthalmic compositions comprising povidone iodine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011103865546A CN102429862B (zh) | 2011-11-29 | 2011-11-29 | 一种聚维酮碘眼用缓释滴眼液 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102429862A true CN102429862A (zh) | 2012-05-02 |
CN102429862B CN102429862B (zh) | 2013-05-01 |
Family
ID=45978452
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011103865546A Active CN102429862B (zh) | 2011-11-29 | 2011-11-29 | 一种聚维酮碘眼用缓释滴眼液 |
Country Status (4)
Country | Link |
---|---|
US (1) | US9308173B2 (zh) |
EP (1) | EP2785328B1 (zh) |
CN (1) | CN102429862B (zh) |
WO (1) | WO2013078998A1 (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106509987A (zh) * | 2016-11-30 | 2017-03-22 | 湖南中烟工业有限责任公司 | 一种可降低主流烟气中苯酚含量的卷烟滤棒添加剂及其制备方法和应用 |
CN108883064A (zh) * | 2016-04-08 | 2018-11-23 | 梅迪维斯责任有限公司 | 包含pvp-i的眼用组合物 |
CN110799179A (zh) * | 2017-07-04 | 2020-02-14 | 富陆凯米有限责任公司 | 水溶性提高的包含碘试剂及氯化钠的固体组合物及包含其水溶液的眼、口腔、鼻腔或吸入用抗病毒及抗菌组合物 |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190049931A (ko) * | 2009-12-15 | 2019-05-09 | 포어사이트 바이오쎄라퓨틱스, 인코퍼레이티드 | 무자극성 안과용 포비돈-요오드 조성물 |
ITTO20120258A1 (it) * | 2012-03-21 | 2013-09-22 | Fond Istituto Italiano Di Tecnologia | Materiali compositi polimerici con proprieta' antimicrobiche e biodegradabili e loro usi. |
US20160366879A1 (en) | 2015-06-22 | 2016-12-22 | Infection Containment Company, LLC | Topical antiseptic system |
EP3318280A4 (en) * | 2015-07-01 | 2018-08-22 | Santen Pharmaceutical Co., Ltd | Depot preparation containing citric acid ester |
WO2017074965A1 (en) | 2015-10-25 | 2017-05-04 | Iview Therapeutics, Inc. | Pharmaceutical formulations that form gel in situ |
EP3618613A4 (en) | 2017-05-05 | 2021-01-20 | Pamel, Gregory J. | COMPOSITION CONTAINING CHLORINE DIOXIDE AND ITS METHODS OF USE |
WO2019009630A1 (ko) * | 2017-07-04 | 2019-01-10 | 김대황 | 수용해성이 향상된 요오드제 및 염화나트륨을 포함하는 고체 조성물 및 이의 수용액을 포함하는 눈, 구강용, 비강용 또는 흡입용 항바이러스 및 항균 조성물 |
US10292998B1 (en) | 2018-08-07 | 2019-05-21 | Ahad Mahootchi | Compositions and methods for prevention and treatment of eye infections |
US20210401878A1 (en) * | 2019-08-18 | 2021-12-30 | Iview Therapeutics, Inc. | Stable Pharmaceutical Articles Containing Dilute Povidone Iodine Formulations |
CN110559175A (zh) * | 2019-08-27 | 2019-12-13 | 陈文龙 | 一种结膜囊消毒溶液及其使用方法和装置 |
GB2588440A (en) | 2019-10-24 | 2021-04-28 | Io Cyte Ltd | Swellable antimicrobial fibre |
GB2588442A (en) | 2019-10-24 | 2021-04-28 | Io Cyte Ltd | Antimicrobial material |
GB2588439A (en) | 2019-10-24 | 2021-04-28 | Io Cyte Ltd | Swellable antimicrobial fibre |
US20230105599A1 (en) * | 2020-03-28 | 2023-04-06 | Iview Therapeutics, Inc. | Aqueous Formulations Containing Povidone Iodine for Effective Treatment and Prevention of Virus Infections |
EP4023214A1 (en) * | 2021-01-05 | 2022-07-06 | Justus-Liebig-Universität Gießen | Slow-release device for wound disinfection and its usage |
CN114209646B (zh) * | 2021-12-29 | 2024-01-19 | 艾威药业(珠海)有限公司 | 一种聚维酮碘温敏凝胶制剂 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003192598A (ja) * | 2001-12-27 | 2003-07-09 | Mikasa Seiyaku Co Ltd | 創傷治療用製剤 |
CN101278917A (zh) * | 2008-02-28 | 2008-10-08 | 王世锋 | 聚维酮碘阴道片制法 |
US20110171284A1 (en) * | 2010-01-11 | 2011-07-14 | Gilman Miles E | Povidone-iodine and sucrose wound healing dressing |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7300667B1 (en) | 1999-05-27 | 2007-11-27 | Euro-Celtique, S.A. | Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract |
ES2235891T3 (es) | 1999-05-27 | 2005-07-16 | Euro-Celtique S.A. | Uso de antisepticos en la fabricacion de una preparacion farmaceutica para la prevencion y tratamiento de infecciones y/o reestructuracion funcional del tejido en el interior del cuerpo humano. |
US20020061281A1 (en) | 1999-07-06 | 2002-05-23 | Osbakken Robert S. | Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
US7494669B2 (en) * | 2001-02-28 | 2009-02-24 | Carrington Laboratories, Inc. | Delivery of physiological agents with in-situ gels comprising anionic polysaccharides |
GB2380135B (en) * | 2001-09-27 | 2005-01-12 | Johnson & Johnson Medical Ltd | Therapeutic wound dressing |
US20060014786A1 (en) * | 2002-05-17 | 2006-01-19 | Rajeev Raut | Opthalmic pharmaceutical compositions and methods for treating ocular inflammation |
JP4937999B2 (ja) | 2005-04-15 | 2012-05-23 | ベイジン シェンギュイヤオ サイエンス アンド テクノロジー ディブロプメント コー.,エルティーディ | 婦人科薬剤含有アルギン酸ナトリウムミクロスフェア血管塞栓剤およびその調製 |
US20060280809A1 (en) | 2005-06-14 | 2006-12-14 | Leshchiner Adele K | Anti-infective iodine based compositions for otic and nasal use |
US7767217B2 (en) * | 2006-03-14 | 2010-08-03 | Foresight Biotherapeutics | Ophthalmic compositions comprising povidone-iodine |
US20100168074A1 (en) | 2007-04-13 | 2010-07-01 | Christopher Culligan | Freezable Unit Dosage Delivery System and Method of Preparation |
US20090263345A1 (en) | 2008-01-28 | 2009-10-22 | Foresight Biotherapeutics, Inc. | Otic compositions for the treatment of infections of the internal and external ear in mammals |
ES2319158B1 (es) | 2008-12-23 | 2010-01-26 | Grifols, S.A | Composicion de microparticulas biocompatibles de acido alginico para la liberacion controlada de principios activos por via intravenosa. |
KR20190049931A (ko) | 2009-12-15 | 2019-05-09 | 포어사이트 바이오쎄라퓨틱스, 인코퍼레이티드 | 무자극성 안과용 포비돈-요오드 조성물 |
ITTO20120258A1 (it) * | 2012-03-21 | 2013-09-22 | Fond Istituto Italiano Di Tecnologia | Materiali compositi polimerici con proprieta' antimicrobiche e biodegradabili e loro usi. |
-
2011
- 2011-11-29 CN CN2011103865546A patent/CN102429862B/zh active Active
-
2012
- 2012-11-28 WO PCT/CN2012/085456 patent/WO2013078998A1/en active Application Filing
- 2012-11-28 US US14/361,242 patent/US9308173B2/en active Active
- 2012-11-28 EP EP12852821.3A patent/EP2785328B1/en not_active Not-in-force
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003192598A (ja) * | 2001-12-27 | 2003-07-09 | Mikasa Seiyaku Co Ltd | 創傷治療用製剤 |
CN101278917A (zh) * | 2008-02-28 | 2008-10-08 | 王世锋 | 聚维酮碘阴道片制法 |
US20110171284A1 (en) * | 2010-01-11 | 2011-07-14 | Gilman Miles E | Povidone-iodine and sucrose wound healing dressing |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108883064A (zh) * | 2016-04-08 | 2018-11-23 | 梅迪维斯责任有限公司 | 包含pvp-i的眼用组合物 |
CN108883064B (zh) * | 2016-04-08 | 2022-09-16 | 梅迪维斯责任有限公司 | 包含pvp-i的眼用组合物 |
CN106509987A (zh) * | 2016-11-30 | 2017-03-22 | 湖南中烟工业有限责任公司 | 一种可降低主流烟气中苯酚含量的卷烟滤棒添加剂及其制备方法和应用 |
CN110799179A (zh) * | 2017-07-04 | 2020-02-14 | 富陆凯米有限责任公司 | 水溶性提高的包含碘试剂及氯化钠的固体组合物及包含其水溶液的眼、口腔、鼻腔或吸入用抗病毒及抗菌组合物 |
Also Published As
Publication number | Publication date |
---|---|
EP2785328A1 (en) | 2014-10-08 |
WO2013078998A1 (en) | 2013-06-06 |
US20140322345A1 (en) | 2014-10-30 |
CN102429862B (zh) | 2013-05-01 |
EP2785328A4 (en) | 2015-04-08 |
US9308173B2 (en) | 2016-04-12 |
EP2785328B1 (en) | 2017-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102429862B (zh) | 一种聚维酮碘眼用缓释滴眼液 | |
DE60020351T2 (de) | Azalid-antibiotika zur topischen behandlung oder vorbeugung okulärer infektionen | |
CN107847604B (zh) | 眼用原位凝胶处方 | |
TW200826963A (en) | Water insoluble polymer matrix for drug delivery | |
JP2015013863A (ja) | 増大した前眼部クリアランス速度を有するα−2アドレナリン受容体アゴニストを用いる眼科治療 | |
JP2001527574A (ja) | 眼科用組成物 | |
JP2011503162A (ja) | 固体組成物 | |
KR101961360B1 (ko) | 신규한 요오드포 조성물 및 사용 방법 | |
CN101987109B (zh) | 含有聚维酮碘与环糊精包合糖皮质激素的眼用组合物 | |
CN110869023B (zh) | 原位凝胶形成药物组合物及其在鼻窦疾病中的应用 | |
WO2013029525A1 (zh) | 治疗皮炎的碘聚合物和糖皮质类固醇复方药物组合物 | |
CN103209683A (zh) | 角鲨胺的眼用制剂 | |
KR101723703B1 (ko) | 안구 통증을 치료 또는 예방하기 위한 케토롤락 트로메타민 조성물 | |
US10174006B2 (en) | Topical aqueous ophthalmic compositions containing a 1H-indole-1-carboxamide derivative and use thereof for treatment of ophthalmic disease | |
CA2851492A1 (en) | Ophthalmic gel compositions | |
CN105476730A (zh) | 一种药物纳米脂质载体-人工晶状体系统及其应用 | |
CN105073123B (zh) | 浓缩的氮杂内酯类水性制剂 | |
CN111741749A (zh) | 多靶抑制剂的悬浮液组合物 | |
US20120028947A1 (en) | Ophthalmic Compositions | |
US20230201030A1 (en) | Dissolvable medical device for drugs delivery | |
TWI686211B (zh) | 易於穿透之包覆吉西他濱(Gemcitabine)及順鉑(Cisplatin)組合物 | |
CN102427801A (zh) | 使用硫酸新霉素b乳膏和壳聚糖制备的药用乳膏以及其制备方法 | |
RU2657419C1 (ru) | Фармацевтическая композиция для назального применения | |
US20160338951A1 (en) | Process of preparing aqueous ophthalmic solution of olopatadine | |
CN101390836A (zh) | 抗真菌性眼病缓释毫微粒及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160826 Address after: 241000, Anhui, Wuhu Three Hill Road, No. 15 road, science and technology center, No. 4 Building Patentee after: Keen medical technology (Wuhu) Co., Ltd. Address before: 225300, room 2, building 907, No.1 drug Avenue, Taizhou Economic Development Zone, Jiangsu, Taizhou, China Patentee before: Jiangsu Deda Pharmaceuticals Co., Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20190715 Address after: 519031 Creative Valley, 1889 Huandao East Road, Hengqin New District, Zhuhai City, Guangdong Province, 20 Patentee after: AIWEI Pharmaceutical (Zhuhai) Co., Ltd. Address before: 241000, Anhui, Wuhu Three Hill Road, No. 15 road, science and technology center, No. 4 Building Patentee before: Keen medical technology (Wuhu) Co., Ltd. |
|
TR01 | Transfer of patent right |